World journal of gastroenterology : WJG
-
World J. Gastroenterol. · Jan 2014
Review Meta AnalysisCombination of chemotherapy and immunotherapy for colon cancer in China: a meta-analysis.
To investigate whether autologous dendritic cell (DC)-cytokine-induced killer (CIK) cell therapy is able to improve the therapeutic efficacy of chemotherapy in colon cancer. ⋯ The combination of DC-CIK immunotherapy and chemotherapy was superior in prolonging the survival time and enhancing immunological responses.
-
World J. Gastroenterol. · Jan 2014
Portal inflow preservation during portal diversion in small-for-size syndrome.
To investigate the impact of portal inflow on liver remnants in a stable pig model of small-for-size syndrome. ⋯ Diversion of portal inflow using MCS reduces portal overflow injury. Excessive diversion of portal inflow inhibits liver regeneration following major hepatectomy. Maintaining portal inflow at an average of 3.2 times above baseline helps promote hypertrophy of the liver remnant and reduce apoptosis.
-
World J. Gastroenterol. · Jan 2014
Review Meta AnalysisDistance management of inflammatory bowel disease: systematic review and meta-analysis.
To review the effectiveness of distance management methods in the management of adult inflammatory bowel disease (IBD) patients. ⋯ Distance management of IBD significantly decreases clinic visit utilization, but does not significantly affect relapse rates or hospital admission rates.
-
World J. Gastroenterol. · Jan 2014
Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
To evaluate the effect of the shunting branch of the portal vein (PV) (left or right) and the initial stent position (optimal or suboptimal) of a transjugular intrahepatic portosystemic shunt (TIPS). ⋯ TIPS placed to the left portal vein with optimal stent position may reduce the risk of hepatic encephalopathy and improve the primary patency rates, thereby prolonging survival.
-
World J. Gastroenterol. · Jan 2014
Review Meta AnalysisEffects of pentoxifylline on nonalcoholic fatty liver disease: a meta-analysis.
To evaluate the effects of pentoxifylline therapy in patients with nonalcoholic fatty liver disease (NAFLD). ⋯ Pentoxifylline therapy results in weight loss, improved liver function and histological changes in patients with NAFLD/NASH. Therefore, pentoxifylline may be a new treatment option for NAFLD.